Diabetic Nephropathies

"Diabetic Nephropathies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.

Descriptor ID	D003928
MeSH Number(s)	C12.777.419.192 C13.351.968.419.192 C19.246.099.875
Concept/Terms	Diabetic Nephropathies Diabetic Nephropathies Nephropathies, Diabetic Nephropathy, Diabetic Diabetic Nephropathy Diabetic Kidney Disease Diabetic Kidney Diseases Kidney Disease, Diabetic Kidney Diseases, Diabetic Diabetic Glomerulosclerosis Diabetic Glomerulosclerosis Kimmelstiel-Wilson Syndrome Kimmelstiel Wilson Syndrome Syndrome, Kimmelstiel-Wilson Kimmelstiel-Wilson Disease Kimmelstiel Wilson Disease Nodular Glomerulosclerosis Glomerulosclerosis, Nodular Glomerulosclerosis, Diabetic Intracapillary Glomerulosclerosis

Below are MeSH descriptors whose meaning is more general than "Diabetic Nephropathies".

Diseases [C]
Male Urogenital Diseases [C12]
Urologic Diseases [C12.777]
Kidney Diseases [C12.777.419]
Diabetic Nephropathies [C12.777.419.192]
Female Urogenital Diseases and Pregnancy Complications [C13]
Female Urogenital Diseases [C13.351]
Urologic Diseases [C13.351.968]
Kidney Diseases [C13.351.968.419]
Diabetic Nephropathies [C13.351.968.419.192]
Endocrine System Diseases [C19]
Diabetes Mellitus [C19.246]
Diabetes Complications [C19.246.099]
Diabetic Nephropathies [C19.246.099.875]

Below are MeSH descriptors whose meaning is more specific than "Diabetic Nephropathies".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Diabetic Nephropathies" by people in this website by year, and whether "Diabetic Nephropathies" was a major or minor topic of these publications.

Bar chart showing 67 publications over 25 distinct years, with a maximum of 7 publications in 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	1	0	1
2001	3	0	3
2002	2	1	3
2003	0	4	4
2004	2	2	4
2005	1	0	1
2006	2	1	3
2007	0	1	1
2008	3	0	3
2009	1	2	3
2010	1	0	1
2011	3	0	3
2012	3	0	3
2013	1	0	1
2014	2	0	2
2015	1	2	3
2017	1	1	2
2018	2	0	2
2019	2	1	3
2021	4	0	4
2022	3	0	3
2023	2	0	2
2024	7	0	7
2025	3	0	3
2026	2	0	2

Below are the most recent publications written about "Diabetic Nephropathies" by people in Profiles.

Dailey RK, Cwiek A, Hamil LC, Timberline S, Kameshwar AKS, Suzuki M, Isaac J, deRonde K, Conaway M, Bennett KM, Baldelomar EJ, Hoch MR, Reidy KJ, Charlton JR. Preterm Birth Increases Susceptibility to Hyperglycemia-Induced Kidney Injury With Sex-Specific Differences in Structural and Molecular Responses. Endocrinol Diabetes Metab. 2026 May; 9(3):e70223.

View in: PubMed
Baldelomar EJ, Charlton JR, Keilhoz S, Kohn B, Wilson LD, Xiong LI, Garfinkel A, Bennett KM. Measuring nephron number in the healthy and diabetic rat kidney in vivo using MRI without contrast agents. Am J Physiol Renal Physiol. 2026 Jun 01; 330(6):F643-F652.

View in: PubMed
Jeddi S, Kashfi K, Ghasemi A. Diabetic nephropathy: Role of nitric oxide. Nitric Oxide. 2025 Dec; 159:89-101.

View in: PubMed
Cwiek A, Dailey RK, Kameshwar AKS, Suzuki M, Isaac J, deRonde K, Conaway M, Bennett KM, Baldelomar EJ, Li T, Wu T, Hoch MR, Chavkin NW, Walker PD, Hirschi KK, Reidy KJ, Charlton JR. Preterm birth increases susceptibility to hyperglycemia induced glomerular alterations in male mice. Sci Rep. 2025 May 29; 15(1):18934.

View in: PubMed
Toyoda K, Takahashi T, Tanaka Y, Suzuki Y, Yokoyama H, Shoda T, Chambers JK, Uchida K. Renal effects of excessive fructose intake in Spontaneously Diabetic Torii-Leprfa (SDT fatty) rats. J Toxicol Sci. 2025; 50(12):727-740.

View in: PubMed
Takamiya Y, Imanaga C, Abe I, Kobayashi K, Ike A, Kawamura A, Urata H. Long-term renoprotective effect of luseogliflozin in type 2 diabetes patients: CHikushi Anti-diabetes mellitus Trial-Lusefi (CHAT-Lu). Drug Discov Ther. 2025 Jan 14; 18(6):336-342.

View in: PubMed
Chuang AE, Chen YL, Chiu HJ, Nguyen HT, Liu CH. Nasal administration of polysaccharides-based nanocarrier combining hemoglobin and diferuloylmethane for managing diabetic kidney disease. Int J Biol Macromol. 2024 Dec; 282(Pt 1):136534.

View in: PubMed
Lee HJ, Min L, Gao J, Matta S, Drel V, Saliba A, Tamayo I, Montellano R, Hejazi L, Maity S, Xu G, Grajeda BI, Roy S, Hallows KR, Choudhury GG, Kasinath BS, Sharma K. Female Protection Against Diabetic Kidney Disease Is Regulated by Kidney-Specific AMPK Activity. Diabetes. 2024 Jul 01; 73(7):1167-1177.

View in: PubMed
Darshi M, Kugathasan L, Maity S, Sridhar VS, Fernandez R, Limonte CP, Grajeda BI, Saliba A, Zhang G, Drel VR, Kim JJ, Montellano R, Tumova J, Montemayor D, Wang Z, Liu JJ, Wang J, Perkins BA, Lytvyn Y, Natarajan L, Lim SC, Feldman H, Toto R, Sedor JR, Patel J, Waikar SS, Brown J, Osman Y, He J, Chen J, Reeves WB, de Boer IH, Roy S, Vallon V, Hallan S, Gelfond JA, Cherney DZ, Sharma K. Glycolytic lactate in diabetic kidney disease. JCI Insight. 2024 Jun 10; 9(11).

View in: PubMed
Feng Y, Sun Z, Fu J, Zhong F, Zhang W, Wei C, Chen A, Liu BC, He JC, Lee K. Podocyte-derived soluble RARRES1 drives kidney disease progression through direct podocyte and proximal tubular injury. Kidney Int. 2024 07; 106(1):50-66.

View in: PubMed

People

Explore

Similar Concepts

Top Journals